248 filings
Page 5 of 13
8-K
z79vu 2haxazru
14 Nov 17
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
12:00am
8-K
g47y 4rs18kge4
25 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K/A
fen8 xy0p
17 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
j50h yv57w6n2215vl
13 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
wwfvai6252d
7 Aug 17
Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements
12:00am
8-K
ei9o9b9nkb8 1cppxqh
1 Aug 17
Threshold Pharmaceuticals Announces Results of Annual Meeting of Stockholders
12:00am
8-K
4rtu4u o3eo2e2
20 Jul 17
Other Events
12:00am
8-K
xxc oi02f5t1allvhb8
22 Jun 17
Completion of Acquisition or Disposition of Assets
12:00am
8-K
er6v7
2 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
79k1ej63y 1nmiz
15 May 17
Threshold Pharmaceuticals Reports First Quarter Financial Results
12:00am
8-K
v3tk1xhyg6hs
30 Mar 17
Regulation FD Disclosure
12:00am
8-K
tk0df3z
29 Mar 17
Regulation FD Disclosure
12:00am
8-K
p0oz xt5c8btxp0vswsc
27 Mar 17
Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
7qu8stt
17 Mar 17
Threshold Pharmaceuticals and Molecular Templates Agree to Combine
12:00am
8-K
s1evkg9ek
15 Nov 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
iwt 60a4d
7 Nov 16
Threshold Pharmaceuticals Reports Third Quarter Financial Results
12:00am
8-K
rnh8qiwt0qmxk 7lqa
18 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
i5wc55amgw1wdescvac
30 Sep 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
13ktxkjttbdimwj
29 Sep 16
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
12:00am
8-K
mbe2hjqbjvtoq964h
13 Sep 16
Other Events
12:00am